Skip to main content

Advertisement

SpringerLink
Log in

Bone and marrow imaging: do we know what we seeand do we see what we want to know?

  • Focus on...
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Basu S, Alavi A. Bone marrow and not bone is the primary site for skeletal metastasis: critical role of [18F]fluorodeoxyglucose positron emission tomography in this setting. J Clin Oncol 2007;25(10):1297; author reply 1297–9.

    Article  PubMed  Google Scholar 

  2. Blebea JS, Houseni M, Torigian DA, Fan C, Mavi A, Zhuge Y, et al. Structural and functional imaging of normal bone marrow and evaluation of its age-related changes. Semin Nucl Med 2007;37(3):185–94.

    Article  PubMed  Google Scholar 

  3. Zamagni E, Nanni C, Patriarca F, Englaro E, Castellucci P, Geatti O, et al. A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma. Haematologica 2007;92(1):50–5.

    PubMed  Google Scholar 

  4. Dankerl A, Liebisch P, Glatting G, Friesen C, Blumstein NM, Kocot D, et al. Multiple myeloma: molecular imaging with 11C-methionine PET/CT—initial experience. Radiology 2007;242(2):498–508.

    Article  PubMed  Google Scholar 

  5. Kim MR, Roh JL, Kim JS, Choi SH, Nam SY, Kim SY. 18F-fluorodeoxyglucose-positron emission tomography and bone scintigraphy for detecting bone metastases in patients with malignancies of the upper aerodigestive tract. Oral Oncol 2007 Mar 9; [Epub ahead of print].

  6. Specht JM, Tam SL, Kurland BF, Gralow JR, Livingston RB, Linden HM, et al. Serial 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) to monitor treatment of bone-dominant metastatic breast cancer predicts time to progression (TTP). Breast Cancer Res Treat 2007; [Epub ahead of print].

  7. Taira AV, Herfkens RJ, Gambhir SS, Quon A. Detection of bone metastases: assessment of integrated FDG PET/CT imaging. Radiology 2007;243(1):204–11.

    PubMed  Google Scholar 

  8. Ghanem NA, Pache G, Lohrmann C, Brink I, Bley T, Kotter E, et al. MRI and 18FDG-PET in the assessment of bone marrow infiltration of the spine in cancer patients. Eur Spine J 2007; [Epub ahead of print].

  9. Wicha MS. Cancer stem cells and metastasis: lethal seeds. Clin Cancer Res 2006;12(19):5606–7.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Radiological Sciences, University of Milan, Unit of Nuclear Medicine, Hospital San Paolo, Via Antonio di Rudinì, 8, 20142, Milan, Italy

    Giovanni Lucignani

Authors
  1. Giovanni Lucignani
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Giovanni Lucignani.

Additional information

The commentaries in this section derive from a literature search and include summaries of recently published articles compiled and linked to each other by extensive use of the text contained in the articles examined.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lucignani, G. Bone and marrow imaging: do we know what we seeand do we see what we want to know?. Eur J Nucl Med Mol Imaging 34, 1123–1126 (2007). https://doi.org/10.1007/s00259-007-0473-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-007-0473-7

Keywords

Search

Navigation